Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial

BACKGROUND: The incidence of type 2 diabetes in pregnancy is rising and rates of serious adverse maternal and fetal outcomes remain high. Metformin is a biguanide that is used as first-line treatment for non-pregnant patients with type 2 diabetes. We hypothesize that metformin use in pregnancy, as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Feig, Denice S., Murphy, Kellie, Asztalos, Elizabeth, Tomlinson, George, Sanchez, Johanna, Zinman, Bernard, Ohlsson, Arne, Ryan, Edmond A., Fantus, I. George, Armson, Anthony B., Lipscombe, Lorraine L., Barrett, Jon F.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952061/
https://www.ncbi.nlm.nih.gov/pubmed/27435163
http://dx.doi.org/10.1186/s12884-016-0954-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952061/
https://www.ncbi.nlm.nih.gov/pubmed/27435163
http://dx.doi.org/10.1186/s12884-016-0954-4

Ejemplares similares